Latest Annual Report
Filed: 2026-03-24
Key Insights
- The company's technology development revenue, a key metric, decreased by 15% year-over-year, indicating potential challenges in its partnership and licensing business.
- Absci has expanded its at-the-market offering program, providing additional flexibility to raise capital, though this could potentially dilute existing shareholders.
- The company's research and development expenses increased by 20% year-over-year, suggesting a continued focus on innovation and product development.